China Biological Sample Handling market is expected to grow at CAGR of around 9.7% during the forecast period. China’s market has both medium and long-term potential in the biological sample handling market in the life science industry. This is majorly due to its large pharmaceutical market size, presence of a number of biobanks, and fluctuating disease profile, Furthermore, the Chinese economy is becoming an R&D concentrated economy coupled with the presence of a wide range of CROs. A biobanking infrastructure plays a significant role in the collection, storage, and usage of human biological samples.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/china-biological-sample-handling-market
Chinese biobank development has made great progress in recent years. This is certainly due to the increasing recognition of the importance of investing in biobanking and research infrastructure, in particular, owing to which, the Government of China is significantly providing funding for biobanking. The most recent and largest development in biobanks is the establishment of Shenzhen-based China National GeneBank (CNGB), a commercial genomics company. Through the development of biobanks in the country, China is focusing on laying a foundation to promote the R&D of translational medicine, personalized medicine, and life science industry, in order to improve the treatment of most prevailing diseases in the country.
Stem cell therapy is a promising method for treating patients with a wide range of diseases and injuries. Increasing government funding for scientific research has promoted rapid developments in stem-cell research in China. According to National Institutes of Health, China has been able to establish around 100 stem cell banks; 10 stem cell drugs are currently in the approval process, and more than 400 stem cell-based clinical trials were registered in the country in 2017. This, in turn, is anticipated to propel the demand for biological sample handling in these clinical trials in China in the near future. China has increased its investments in the biomedical research, invested heavily in stem cell research medicine in recent years.
China Biological Sample Handlings Market Segmentation
By Storage Type
- Cold Storage
- Room Temperature Storage
By Application
- Drug Discovery
- Forensic Investigation
- DNA Extraction
- Proteomics and Genomics Studies
- Others
By Ownership
- Commercial
- Academic/Research
A full report of China Biological Sample Handling Market available @ https://www.omrglobal.com/industry-reports/china-biological-sample-handling-market
Company Profiles
- Abbott Laboratories
- Becton, Dickinson And Co.
- Brooks Automation, Inc.
- Fisher BioServices
- Sigma-Aldrich Co. LLC.
- Technidata
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Visit more report at
https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/